| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 8 | 10 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 93 |
| Expenses | 8 | 9 | 7 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 87 |
| EBITDA | 0 | 1 | 1 | -1 | -0 | 0 | -0 | -0 | -0 | -1 | -1 | 5 |
| Operating Profit % | 5 % | 5 % | 6 % | -57 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 0 % | 6 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | -2 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | 6 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Net Profit | 0 | 0 | 0 | -2 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | 5 |
| EPS in ₹ | 0.16 | 0.06 | 0.30 | -5.37 | -0.38 | -0.14 | -0.41 | -0.42 | -0.77 | -1.68 | -0.99 | 2.09 |
Kabra Drugs
Kabra Drugs
23.09
-1.24
(-5.10%)
Market Cap
54.76 Cr
PE Ratio
11.64
Volume
1,21,737.00
Day High - Low
24.33 - 22.80
52W High-Low
35.52 - 13.46
Key Fundamentals
Market Cap
54.76 Cr
EPS
2.09
PE Ratio
11.64
PB Ratio
1.95
Book Value
12.49
EBITDA
5.33
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-4.40
Debt to Equity
0.08
Actual
Company News
View All News
Kabra Drugs gets LOI for ₹200 Cr plant
Jun 13, 2026
Jun 13, 2026Kabra Drugs received an LOI from the Chhattisgarh Government to set up a ₹200 Crore pharma unit at Nava Raipur. The project aims to create 250 jobs and boost manufacturing capacity.
Kabra Drugs shareholders approve name changeJun 12, 2026
Jun 12, 2026Shareholders approved changing the company's name and altering its object clause. The resolutions passed with 99.85% of votes in favor.
Kabra Drugs publishes audited resultsJun 03, 2026
Jun 03, 2026Kabra Drugs Limited published audited financial results for the quarter and year ended March 31, 2026, in English and Hindi newspapers.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,874.80 | #1 4,49,827.32 | 38.82 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 65.03 | |
6,557.50 | 1,74,081.02 | 69.38 | 10,560.00 | 8.73 | 2,520 | 13.44 | 43.32 | |
4,657.60 | 1,57,634.35 | 71.51 | 13,886.20 | 20.34 | 2,138 | -26.91 | 66.05 | |
1,454.10 | 1,17,459.39 | 30.13 | 29,044.60 | 2.24 | 3,870 | -55.32 | 68.02 | |
1,375.70 | 1,14,821.84 | 27.10 | 33,593.30 | -0.44 | 3,998 | -86.05 | 73.77 | |
1,121.30 | 1,12,829.02 | 21.63 | 26,719.70 | 13.65 | 5,242 | 7.82 | 66.06 | |
2,409.30 | 1,10,115.42 | #1 20.00 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 66.98 | |
2,486.00 | 1,02,623.34 | 52.44 | 14,277.60 | 12.03 | 1,750 | 31.75 | 59.48 | |
1,547.50 | 89,879.05 | 25.78 | 33,384.70 | 3.21 | 3,376 | 1.99 | 65.10 | |
1,500.30 | 80,994.68 | 88.02 | 6,867.80 | #1 22.01 | 890 | 21.18 | 70.64 |
Growth Rate
Revenue Growth
15,356.67 %
Net Income Growth
-550.91 %
Cash Flow Change
-2,142.86 %
ROE
-93.53 %
ROCE
-93.53 %
EBITDA Margin (Avg.)
-103.40 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 9 | 9 | 6 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 25 | 86 |
| Fixed Assets | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Current Assets | 6 | 6 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 5 | 25 | 84 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 6 | 4 | 2 | 1 | 1 | 1 | 1 | 1 | 5 | 25 | 0 |
| Total Equity & Liabilities | 9 | 9 | 6 | 2 | 2 | 1 | 1 | 1 | 1 | 5 | 25 | 86 |
| Current Liabilities | 3 | 4 | 3 | 2 | 1 | 1 | 2 | 1 | 1 | 4 | 1 | 57 |
| Non Current Liabilities | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 3 | 3 | 3 | 0 | 0 | 0 | -0 | -0 | -1 | 1 | 25 | 30 |
| Reserve & Surplus | -2 | -2 | -2 | -4 | -4 | -4 | -5 | -5 | -5 | -6 | 1 | 6 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 24 | 24 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 3 | 19 |
| Investing Activities | -0 | -0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Operating Activities | -0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -5 |
| Financing Activities | 1 | -0 | -0 | -1 | 0 | 0 | 0 | 0 | 0 | 3 | 23 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 92.21 % | 96.07 % | 96.08 % | 96.08 % | 96.12 % | 96.00 % | 96.09 % | 95.98 % | 95.97 % | 95.97 % | 95.95 % | 95.92 % | 95.73 % | 95.85 % | 96.19 % | 96.12 % | 95.94 % | 95.61 % | 95.00 % | 91.43 % | 90.92 % |
| Others | 7.79 % | 3.93 % | 3.92 % | 3.92 % | 3.88 % | 4.00 % | 3.91 % | 4.02 % | 4.03 % | 4.03 % | 4.05 % | 4.08 % | 4.27 % | 4.15 % | 3.81 % | 3.88 % | 4.06 % | 4.39 % | 5.00 % | 8.57 % | 9.08 % |
| No of Share Holders | 7,446 | 7,447 | 7,424 | 7,399 | 7,391 | 7,428 | 7,403 | 7,401 | 7,424 | 7,420 | 7,415 | 7,396 | 7,364 | 7,336 | 7,367 | 7,343 | 7,435 | 7,449 | 8,098 | 8,862 | 9,185 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 02 Sept 2020 |  Change Of Name | NA | 02 Sept 2020 | 2.80 | 2.80 |
| 17 Feb 2024 |  Extraordinary General Meeting | NA | 17 Feb 2024 | 6.22 | 6.85 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 8.71 | 9.14 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 9.14 | 9.59 |
| 02 Jan 2025 | Extraordinary General Meeting | NA | 02 Jan 2025 | 9.59 | 10.06 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 10.06 | 10.56 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 11.63 | 11.63 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 19.80 | 20.19 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 18.25 | 17.97 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 19.25 | 20.69 |
| 26 Dec 2025 | Extraordinary General Meeting | NA | 26 Dec 2025 | 29.67 | 29.40 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 29.92 | 33.29 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 25.13 | 25.22 |
Announcements
Closure of Trading Window3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 14, 2026
Jun 14, 2026Revised Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of Rs. 200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma ParkJun 13, 2026
Jun 13, 2026Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of ?200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma ParkJun 13, 2026
Jun 13, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 12, 2026
Jun 12, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 12, 2026
Jun 12, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 03, 2026
Jun 03, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2026
May 30, 2026Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St March 2026.May 29, 2026
May 29, 2026Financial Results For Quarterly & Year Ended 31St March 2026.May 29, 2026
May 29, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May 2026May 29, 2026
May 29, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th May 2026May 29, 2026
May 29, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 29Th May 2026May 21, 2026
May 21, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2026
May 21, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 12, 2026
May 12, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotMay 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 06, 2026
May 06, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 06Th May 2026May 06, 2026
May 06, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 06Th May 2026Apr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateApr 21, 2026
Apr 21, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 21St April 2026Apr 21, 2026
Apr 21, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 21-April-2026Apr 10, 2026
Apr 10, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 07 Th March 2026 As Per Regulation 30 Of SEBI
(Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 07, 2026
Mar 07, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On March 7 2026Feb 26, 2026
Feb 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 16, 2026
Feb 16, 2026Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended On 31St December 2025.Feb 13, 2026
Feb 13, 2026Financial Results For The Quarter Ended 31St December 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Feb 13, 2026
Feb 13, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th February 2026 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 13, 2026
Feb 13, 2026Board Meeting Intimation for Intimation Of Board MeetingFeb 06, 2026
Feb 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On 01St January 2026 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 01, 2026
Jan 01, 2026Closure of Trading WindowDec 30, 2025
Dec 30, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 27, 2025
Dec 27, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMDec 26, 2025
Dec 26, 2025Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 22, 2025
Dec 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 05, 2025
Dec 05, 2025Submission Of Notice Of Extra Ordinary General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirements) Regulations 2015Dec 03, 2025
Dec 03, 2025Appointment Of Secretarial Auditor Of The CompanyNov 28, 2025
Nov 28, 2025Resignation Of Secretarial Auditor Of The CompanyNov 28, 2025
Nov 28, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th November 2025 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 28, 2025
Nov 28, 2025Board Meeting Intimation for Intimation Of Board MeetingNov 20, 2025
Nov 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 17, 2025
Nov 17, 2025Financial Results For The Quarter Ended 30 Th September 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Nov 13, 2025
Nov 13, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On 13 Th November 2025 As Per Regulation 30 Of
SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 13, 2025
Nov 13, 2025Board Meeting Intimation for Intimation Of Board MeetingNov 05, 2025
Nov 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateOct 09, 2025
Oct 09, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Oct 08, 2025
Oct 08, 2025Technical Indicators
RSI(14)
Neutral 50.47
ATR(14)
Less Volatile 2.26
STOCH(9,6)
Neutral 43.92
STOCH RSI(14)
Neutral 62.43
MACD(12,26)
Bullish 0.21
ADX(14)
Weak Trend 14.92
UO(9)
Bearish 32.92
ROC(12)
Uptrend And Accelerating 14.55
WillR(14)
Neutral -48.73
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
